Invivyd (IVVD) Assets Average (2021 - 2025)
Invivyd (IVVD) posted Assets Average of $208.0 million for Q4 2025, up 82.24% on a QoQ basis from $114.1 million in Q3 2025, and up 42.76% year-over-year from $145.7 million in Q4 2024.
Invivyd (IVVD) Assets Average (2021 - 2025) Analysis & Trends
Invivyd's Assets Average history runs 5 years deep, the most recent figure standing at $208.0 million for Q4 2025.
- Quarterly Assets Average rose 42.76% year-over-year to $208.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $208.0 million (up 42.76% YoY) and the FY2025 annual result came in at $203.2 million, up 13.3% from the prior year.
- Assets Average was $208.0 million for Q4 2025 at Invivyd, up from $114.1 million in the prior quarter.
- Across five years, Assets Average topped out at $653.2 million in Q4 2021 and bottomed at $96.4 million in Q2 2025.
- A 5-year average of $315.5 million and a median of $273.6 million in 2023 frame the typical range for Assets Average.
- Peak annual rise in Assets Average reached 42.76% in 2025, while the deepest fall reached 50.9% in 2025.
- Invivyd's Assets Average stood at $653.2 million in 2021, then slumped by 38.16% to $404.0 million in 2022, then slumped by 37.6% to $252.0 million in 2023, then slumped by 42.19% to $145.7 million in 2024, then jumped by 42.76% to $208.0 million in 2025.
- Business Quant data shows IVVD's Assets Average at $208.0 million in Q4 2025, $114.1 million in Q3 2025, and $96.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.30 Bn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 208.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 208.02 Mn |
| Sep 30, 2025 | 114.15 Mn |
| Jun 30, 2025 | 96.44 Mn |
| Mar 31, 2025 | 116.63 Mn |
| Dec 31, 2024 | 145.72 Mn |
| Sep 30, 2024 | 169.63 Mn |
| Jun 30, 2024 | 196.41 Mn |
| Mar 31, 2024 | 222.32 Mn |
| Dec 31, 2023 | 252.05 Mn |
| Sep 30, 2023 | 295.17 Mn |
| Jun 30, 2023 | 332.99 Mn |
| Mar 31, 2023 | 366.87 Mn |
| Dec 31, 2022 | 403.96 Mn |
| Sep 30, 2022 | 454.68 Mn |
| Jun 30, 2022 | 520.44 Mn |
| Mar 31, 2022 | 588.18 Mn |
| Dec 31, 2021 | 653.18 Mn |
| Sep 30, 2021 | 542.13 Mn |